Of note, considering that the CRP and AFP levels may be affected by other diseases not related to HCC (e.g., infection), and there is heterogeneity among patients in terms of their liver function status, treatment line, and the specific ICI type, the integration of additional indicators may help overcome selection bias and optimize the prognostic performance. Here, CRP is linked to hepatocellular carcinoma.